The artificial intelligence sector is about to collide with public markets at unprecedented scale, with three of the most valuable private companies in history racing to list within months of each other and testing whether investors have the appetite, and the capital, to absorb them all.
OpenAI, the ChatGPT maker valued at more than $850 billion by private investors, is preparing to confidentially file a draft IPO prospectus as soon as this week, with Goldman Sachs and Morgan Stanley advising on what could be a September debut.
The filing comes days after a federal jury in Oakland threw out Elon Musk's lawsuit against OpenAI and chief executive Sam Altman, finding that Musk had waited too long to bring his claims that the pair violated an agreement to run the venture as a nonprofit.
That verdict removed what analysts had identified as the single biggest legal obstacle to a public offering.
"Resolving that legal overhang removed a major obstacle to an IPO and likely gave OpenAI the confidence to accelerate its timeline," said Kat Liu, vice president at investment group IPOX, quoted in the New York Post.
OpenAI is not the only colossus heading for the public markets this summer.
SpaceX, which absorbed Musk's AI venture xAI in an all-stock deal earlier this year, valuing the combined entity at $1.25 trillion, is targeting a June 12 listing on the Nasdaq at a valuation of $1.75 trillion, aiming to raise around $75 billion in what would be the largest IPO in history.
Then there is Anthropic, OpenAI's closest rival in the frontier AI model race, which is targeting an October listing that could value the company at or above $900 billion.
The sheer scale of the pipeline is staggering.
Based on mid-point valuation estimates, the combined fundraising from the three offerings alone could approach $200 billion, more capital than all US listings raised collectively between 2022 and 2025.
For OpenAI, the numbers present a complicated picture for prospective public investors.
The company has raised more than $180 billion from private backers and continues to burn cash at a breakneck pace, with internal documents projecting a $14 billion loss for 2026 against roughly $18 billion in revenue.
Projected cash burn has been estimated at approximately $27 billion for the current year, with the company not expected to reach positive free cash flow until 2029 at the earliest.
Some analysts have gone further, concluding that OpenAI faces a $207 billion funding shortfall to execute its own growth plans.
The contrast with Anthropic is striking.
Anthropic's annualised revenue run rate surged from $9 billion at the end of 2025 to more than $30 billion by April, driven overwhelmingly by enterprise demand and the explosive growth of Claude Code, its AI coding tool, which hit $1 billion in annualised revenue within six months of launch.
The company now counts more than 1,000 enterprise clients spending over $1 million annually, a figure that doubled in under two months.
Crucially, Anthropic's training costs are projected at roughly a quarter of OpenAI's over the same period, and the company expects to reach profitability by 2028 or 2029, years ahead of its rival.
SpaceX sits in a different category again, a hybrid aerospace and AI play whose $1.75 trillion target valuation implies a price-to-sales ratio exceeding 80 times, a multiple that has prompted warnings from some analysts that signals of a valuation bubble are already evident.
The question for investors considering all three is whether the market can digest this volume of AI-linked issuance without choking.
The IPO market has been gradually thawing after the brutal 2022 to 2023 freeze, with successful offerings from CoreWeave, Klarna and chipmaker Cerberus demonstrating renewed appetite for growth stories in early 2026.
But there are signs that the AI trade is entering a more volatile phase, with some observers warning of "AI fatigue" among institutional investors who are increasingly demanding proven revenue and a credible path to profitability rather than speculative narratives about future dominance.
Capital is also consolidating around the largest players, creating what some analysts have described as a "liquidity drought" for mid-tier AI companies unable to match the scale of the big three.
For Anthropic, listing last in the queue carries both risks and advantages.
The risk is obvious: by October, investors may have already committed enormous sums to SpaceX and OpenAI, leaving less capital available for a third mega-offering in the same sector.
Prediction market odds of Anthropic listing before OpenAI collapsed from 69% to 20% after the filing news broke.
But Anthropic also has the advantage of watching how the first two offerings are received and calibrating accordingly.
Its revenue trajectory is growing faster than OpenAI's, its cost base is materially lower, and its path to profitability is shorter.
If OpenAI's IPO exposes investor anxiety about enormous losses and uncertain payback periods, Anthropic's more disciplined financial profile could prove to be a powerful differentiator.
The autumn listing window may also benefit from a clearer picture of macroeconomic conditions, with the Federal Reserve's monetary policy direction likely to be more settled by the fourth quarter.
The broader significance of these three offerings extends well beyond their individual share prices.
A successful trio of mega-listings would formally graduate artificial intelligence from private-market curiosity to mainstream public-market asset class, potentially opening exit routes for hundreds of smaller AI ventures and their venture capital backers.
A stumble by any of the three, however, could freeze the window shut for years.